176 related articles for article (PubMed ID: 20214579)
1. Recent advances in pharmacokinetics of polymeric excipients used in nanosized anti-cancer drugs.
Cuong NV; Hsieh MF
Curr Drug Metab; 2009 Oct; 10(8):842-50. PubMed ID: 20214579
[TBL] [Abstract][Full Text] [Related]
2. Poly(ethylene glycol) versus dendrimer prodrug conjugates: influence of prodrug architecture in cellular uptake and transferrin mediated targeting.
Aher N; Banerjee S; Bhansali S; Yadav R; Shidore M; Mhaske S; Chaudhari R; Asai S; Jalota-Badhwar A; Khandare J
J Biomed Nanotechnol; 2013 May; 9(5):776-89. PubMed ID: 23802407
[TBL] [Abstract][Full Text] [Related]
3. Linear-Dendritic Polymer-Platinum Complexes Forming Well-Defined Nanocapsules for Acid-Responsive Drug Delivery.
Liu K; Xiang J; Wang G; Xu H; Piao Y; Liu X; Tang J; Shen Y; Zhou Z
ACS Appl Mater Interfaces; 2021 Sep; 13(37):44028-44040. PubMed ID: 34499483
[TBL] [Abstract][Full Text] [Related]
4. Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo KF; Chang EH
Trends Biotechnol; 2008 Oct; 26(10):552-8. PubMed ID: 18722682
[TBL] [Abstract][Full Text] [Related]
5. Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers.
Chen J; Ding J; Xiao C; Zhuang X; Chen X
Biomater Sci; 2015 Jul; 3(7):988-1001. PubMed ID: 26221934
[TBL] [Abstract][Full Text] [Related]
6. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers in oncology: an expanding horizon.
Tekade RK; Kumar PV; Jain NK
Chem Rev; 2009 Jan; 109(1):49-87. PubMed ID: 19099452
[No Abstract] [Full Text] [Related]
9. The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles.
Wang JL; Du XJ; Yang JX; Shen S; Li HJ; Luo YL; Iqbal S; Xu CF; Ye XD; Cao J; Wang J
Biomaterials; 2018 Nov; 182():104-113. PubMed ID: 30114562
[TBL] [Abstract][Full Text] [Related]
10. Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy.
Sun L; Wu Q; Peng F; Liu L; Gong C
Colloids Surf B Biointerfaces; 2015 Nov; 135():56-72. PubMed ID: 26241917
[TBL] [Abstract][Full Text] [Related]
11. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy.
Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S
Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
13. Release of adriamycin from poly(gamma-benzyl-L-glutamate)/poly(ethylene oxide) nanoparticles.
Oh I; Lee K; Kwon HY; Lee YB; Shin SC; Cho CS; Kim CK
Int J Pharm; 1999 Apr; 181(1):107-15. PubMed ID: 10370207
[TBL] [Abstract][Full Text] [Related]
14. Novel nanoparticles generated by polymeric amphiphiles with pi-pi conjugated small molecules for anti-tumor drug delivery.
Deng X; Xu X; Lai Y; He B; Gu Z
J Biomed Nanotechnol; 2013 Aug; 9(8):1336-44. PubMed ID: 23926799
[TBL] [Abstract][Full Text] [Related]
15. Hyperbranched PEG-based supramolecular nanoparticles for acid-responsive targeted drug delivery.
Chen X; Yao X; Wang C; Chen L; Chen X
Biomater Sci; 2015 Jun; 3(6):870-8. PubMed ID: 26221847
[TBL] [Abstract][Full Text] [Related]
16. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.
Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F
J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902
[TBL] [Abstract][Full Text] [Related]
17. PEGylated Dendrimer-Doxorubicin Cojugates as pH-Sensitive Drug Delivery Systems: Synthesis and In Vitro Characterization.
She W; Pan D; Luo K; He B; Cheng G; Zhang C; Gu Z
J Biomed Nanotechnol; 2015 Jun; 11(6):964-78. PubMed ID: 26353586
[TBL] [Abstract][Full Text] [Related]
18. Polymer-protein and polymer-drug conjugates in cancer therapy.
Thanou M; Duncan R
Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
[TBL] [Abstract][Full Text] [Related]
19. BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers.
Mahmoudi A; Jaafari MR; Ramezanian N; Gholami L; Malaekeh-Nikouei B
Int J Pharm; 2019 Jun; 564():77-89. PubMed ID: 30991135
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
